Interleukin-1β-induced effects on plasma oxytocin and arginine vasopressin: Role of adrenal steroids and route of administration

NeuroImmunoModulation

Volumn 3, Issue 6, 1996, Pages 358-363

  Harbuza, Michael S ^a   Chover Gonzalez, Antonio J ^b   Condea, Gillian L ^a   Renshaw, Derek ^a   Lightman, Stafford L ^a   Jessop, David S ^a  

^a BRISTOL ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF CÁDIZ   (Spain)

Author keywords

Corticosterone; Dexamethasone; Interleukin 1 ; Oxytocin; Vasopressin

Indexed keywords

ARGIPRESSIN; CORTICOSTERONE; CYTOKINE; DEXAMETHASONE; GLUCOCORTICOID; OXYTOCIN; RECOMBINANT INTERLEUKIN 1BETA; VASOPRESSIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; HORMONE RELEASE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOSTIMULATION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NEUROENDOCRINOLOGY; NEUROHYPOPHYSIS; NONHUMAN; OXYTOCIN RELEASE; PRIORITY JOURNAL; RAT;

ADRENAL CORTEX HORMONES; ADRENALECTOMY; ANIMALS; ARGININE VASOPRESSIN; CORTICOSTERONE; DEXAMETHASONE; DRUG ADMINISTRATION ROUTES; HUMANS; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENTRICULAR; INTERLEUKIN-1; MALE; OSMOLAR CONCENTRATION; OXYTOCIN; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS;

EID: 0030422911     PISSN: 10217401     EISSN: 14230216     Source Type: Journal    
DOI: 10.1159/000097296     Document Type: Article

References (55)

1. Harbuz MS, Lightman SL: Stress and the hypo-thalamo-pituilary-adrenal axis: Acute, chronic and immunological activation, J Endocrinol 1992;134:327-339.
2. Lightman SL. Young WS III: Corticotrophin-releasing factor, vasopressin and proopiomelanocortin mRNA responses to stress and opiates in the rat. J Physiol 1988:403:511-523.
3. Young WS III. Mezey E. Siegel RE: Vasopressin and oxytocin mRNA's in adrcnalcctomized and Braltleboro rats: Analysis by quantitative in situ hybridization histochemistry. Mol Brain Res 1986;1:231-241.
4. Stillman MA. Rech LD. Rosario SL. Seif SM. Robinson AG. Zimmerman EA: The effect of adrenalectomy and glucocorticoid replacement on vasopressin and vasopressin-ncurophysin in the zona externa of the median eminence of the rat. Endocrinology 1977;101:42-49.
5. Vcrbalis JG, Strieker EM, Robinson AG, Hoffman GE: Cholecystokinin activates c-fos expression in hypothalamic oxytocin and corticotropin-releasing hormone neurons. J Ncurocn-docrinol 1991;3:205-213.
6. Gibbs DM: Measurement of hypothalamic corticotropin-releasing factors in hypophyseal portal blood. Fed Proc 1985;44:203-206.
7. Plotsky PM: Hypophyseotropic regulation of adcnohypophyscal adrenocorticotropin secretion. Fed Proc 1985:44:207-213.
8. Husain MK, Manger WM, Rock TM. Weiss RJ. Frantz AG: Vasopressin release due to manual restraint in the rat: Role of body compression and comparison with other stressful stimuli. Endocrinology 1979:104:641-644.
9. Williams TDM, Carter DA, Lightman SL: Sexual dimorphism in the posterior pituitary response to stress in the rat. Endocrinology 1985; 116:738-740.
10. Onaka T. Hamamura M. Yagi K: Potentiation of vasopressin secretion by footshocks in rats. JpnJ Physiol 1986;36:1253-1260.
11. Ivanyi T, Wieganl VM. de Wied D: Differential effects of emotional and physical stress on the central and peripheral secretion of neurohypophysial hormones in male rats. Life Sci 1991;48:1309-1316.
12. Yagi K. Onaka T: Stress and nociceptive inputs to VP neurons. Colloque INSERM. London. Libbey Eurotcxt, 1991, pp 245-255.
13. Choivdrcy HS. Jcssop DS. Patel H. Lightman SL: Altered adrenocorticotropin. corticosterone and oxytocin responses during chronic salt load. Neuroendocrinology 1991:54:635-638.
14. Suda T. Tozawa F. Ushiyama T. Sumitomo T. Yamada M. Demura H: Interleukin-1 stimulates corticotropin-releasing factor gene expression in rat hypothalamus. Endocrinology 1990; 126:1223-1228.
15. Harbuz MS, Stephanou A, Sarlis N. Lightman SL: The effecls of recombinant interleukin (IL)-1 a. IL-lp or IL-6 on hypothalamo-pitu-itary-adrenal axis activation. J Endocrinol 1992;133:349-355.
16. Berkenbosch F, De Gocij DEC, Del Rcy A, Besedovsky HO: Neuroendocrine, sympathetic and metabolic responses induced by interleukin-1. Neuroendocrinology 1959:50:570-576.
17. Sapolsky R. Rivier C. Yamamoto G. Plotsky P. Vale VV: Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science 1987:238:522-524.
18. Berkcnbosch F, Van Ocrs J, Del Rey A, Tildcrs F, Besedovsky H: Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1. Science 1987:238:524-526.
19. Watanabe T. Morimoto A. Sakata Y. Murakami N: ACTH response induced by interleukin-1 is mediated by CRF secretion stimulated by hypothalamic PGE. Experientia 1990:46: 481-484.
20. Spincdi E, Hadid R, Daneva T, Gaillard RC: Cytokines stimulate the CRH but not the vasopressin neuronal system: Evidence for a median eminence site of interleukin-6 action. Ncurocndocrinology 1992;56:46-53.
21. Whitnall MH. Perlstcin RS. Mougey EH. Neta R: Effects of interleukin-1 on the stress-responsive and -nonrcsponsive subtypes of corticotropin-releasing hormone neurosecretory axons. Endocrinology 1992:131:37-44.
22. Chover-Gonzalez AJ, Harbu MS, Lightman SL: Effect of adrenalectomy and stress on interleukin-I p mediated activation of hypothalamic corticotropin releasing factor mRNA. J Ncu-roimmunol 1993:42:155-160.
23. Christensen JD. Hansen EW. Fjalland B: Interleukin-I p stimulates the release of vasopressin from rat neurohypophysis. Eur J Pharmacol 1989;171:233-235.
24. Nakatsura K, Ohgo S, Oki Y, Matsukura S: Interleukin-1 (IL-1) stimulates arginine vasopressin (AVP) release from superfused rat hy-pothalamo-neurohypophyscal complexes independently of cholinergic mechanism. Brain Res 1991:554:38-45.
25. Yasin SA, Costa A, Forsling ML, Grossman A: Interleukin-ipand imerleukin-6 stimulate neurohypophysial hormone release in vitro. J Neu-roendocrinol 1994:6:179-184.
26. Naito Y. Fukata J. Shindo K, Ebisui O. Murakami N. Tominaga T. Nakai Y. Mori K. Kast-ing NW, Imura H: Effects of interleukins on plasma arginine vasopressin and oxytocin levels in conscious, freely moving rats. Biochcm BiophysResCommun 1991; 174:1189-1195.
27. Raber J, Pich EM, Koob GF, Bloom FE: IL-lp potentiates the acetylcholine-induced release of vasopressin from the hypothalamus in vitro, but not from the amygdala. Ncuroendocrinolo-gy 1994;59:208-217.
28. Chover-Gonzalez AJ, Lightman SL, Harbuz MS: An investigation of the effects of interleukin-Ip on plasma arginine vasopressin in the rat: Role of adrenal steroids. J Endocrinol 1994;142:361-366.
29. Loxley HD. Cowell A-M. Flower RJ. Buckingham JC: Modulation of the hypothalamo-pitu-itary-adrenocortical responses to cytokines in the rat by lipocortin I and glucocorticoids: A role for lipocortin 1 in the feedback inhibition ofCRF-4! release? Neuroendoerinology 1993; 57:801-814.
30. Bertini R. Bianchi M. Ghczzi P: Adrenalectomy sensitizes mice to the lethal effects of interleukin I and tumor necrosis factor. J Exp Med 1988:167:1708-1712.
31. Robinson ICAF: The development and evaluation of a sensitive and specific radioimmunoassay for oxytocin in uncxtracted plasma. J Immunoassay 1980:1:323-347.
32. Lightman SL. Harbuz MS. Knight RA. Chow-drcy HS: CRF mRNA in normal and stress conditions. Ann N Y Acad Sci 1993:697:28-38.
33. Cunningham ET. De Souza EB: Interleukin 1 receptors in the brain and endocrine tissues. Lmmunol Todav 1993:14:171-176.
34. Pamet P. Brunke DL. Goujon E. Mainard JD. Biragyn A. Arkins S. Dantzer R. Kelley KW: Molecular identification of two types of interleukin-1 receptors in the murine pituitary' gland. J Neuroendocrinol 1993;5:213-219.
35. French RA. Zachary JF. Dantzer R. Frawley LS. Chizzonite R. Pamet P. Kelley KW: Dual expression of pSO ty pe 1 and p68 type II interleukin-1 receptors on anterior pituitary cells sythcsizing growth hormone. Endocrinology 1996:137:4027-4036.
36. Fuxe K, Wikstrom A-C, Okrct S, Agnati LF, Harfstrand A, Yu Z-Y, Granholm L, Zoli M, Vale W, Gustafson J-A: Mapping of glucocorticoid receptor immunorcactive neurons in the rat tel-and diencephalon using a monclonal antibody against rat liver GR. Endocrinology 1985:117:1803-1812.
37. Kiss Z, van Eckclcn JAM. Reul JMHM, Wesl-phal HM. de Kloct ER: Glucocorticoid receptor in magnoccllular neurosecretory cells. Endocrinology 1988:122:444-449.
38. Uht RM, McKelvy JF, Harrison RW. Bohn MC: Demonstration of glucocorticoid receptor-like immunorcaetivity in glucocorticoid-sensitive vasopressin and CRF neurons in the hypothalamic PVN. J Neurosci Res 1988:19: 405-411.
39. Berghom KA. Knapp LT. Hoffman GE. Sherman TG: Induction of glucocorticoid receptor expression in hypothalamic magnocellular vasopressin neurons duringchronic hypoosmolal-ily. Endocrinology 1995:135:804-807.
40. Rinaman L, Hoffman GE, Dohanics J, Le WW, Strieker EM, Vcrbalis JG: Cholecystoki-nin activates catecholamincrgic neurons in the caudal medulla that innervate the paraventricular nucleus of the hypothalamus in rats. J Comp Neurol 1995;360:246-256.
41. Elmquist JK. Ackermann MR, Register KB. Rimlcr RB, Ross LR. Jacobson CD: Induction of fos-like immunorcaetivity in the rat brain following Pasteurella muliockh endotoxin administration. Endocrinology 1993:133:3054-3057.
42. Wan W. Janz L. Vricnd CY. Sorensen CM. Greenberg AH. Nance DM: Differential induction of c-fos immunorcaetivity in hypothalamus and brain stem nuclei following central and peripheral administration of endotoxin. Brain Res Bull 1993:32:581-587.
43. Hare AS. Clarke G. Tolchard S: Bacterial lipo-polysaccharidc-induccd changes in fos protein expression in the rat brain: Correlation with thermoregulatory changes and plasma corticosterone. J Neuroendocrinol 1995:7:791-799.
44. Day HEW. Akil: Differential pattern of c-fos mRNA in rat brain following central and systemic administration of interleukin-1-beta: Implications for mechanisms of action. Neuroendocrinology 1996:63:207-218.
45. Lowcy A: Central autonomic pathways. New York. Oxford University Press. 1990. pp 88-103.
46. Fleshner M. Goehler L. Herman J. Rclton J. Maier S. Watkins L: Intcrleukin-ip induced corticosterone elevation and hypothalamic NE depletion is vagally mediated. Brain Res Bull 1995:37:605-610.
47. Goehler L. Busch C. Tartaglia N. Rclton J. Sisk D. Maier S. Watkins L: Blockade of cytokine induced conditioned taste aversion by sub-diaphragmatic vagotomy: Further evidence for vagal mediation of immune-brain communication. Neursci Let! 1995:185:163-166.
48. Laye S, Bluthe R-M, Kent S, Combe C, Medina C, Pamet P, Kelley K, Dantzer R: Subdiapha-ragmatic vagotomy blocks induction of IL-lp mRNA in mice brain in response to peripheral LPS. Am J Physiol 1995:265:R1327-R1331.
49. Watkins LR. Goehler LE. Rclton JK. Tartaglia N. Silbert L. Martin D. Maier SF: Blockade of interleukin-1 induced hyperthermia by sub-diaphragmatic vagotomy: Evidence for vagal mediation of immune-brain communication. Neurosci Lett 1995:183:27-31.
50. Kapcala LP. He JR. Gao Y. Piper JO. DeTolla LJ: Subdiaphragmatic vagotomy inhibits intraabdominal interleukin-ip stimulation of adre-nocorticotropin secretion. Brain Res 1996:728: 247-254.
51. Landgraf R. Neuman 1. Holsboer F. Pittman QJ: Interleukin-1 beta stimulates both central and periphreal release of vasopressin and oxytocin in the rat. Eur J Neurosci 1995:7:592-598.
52. Munck A. Guyre PM. Holbrook NJ: Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. En-docrRcv 1984:5:25-44.
53. Poulin P, Pittman QJ: Possible involvement of brain oxytocin in modulating vasopressin antipyretic action. Am J Physiol 1993:265:R151-R156.
54. Parrott RF. Veilucci SV. Forsling ML. Goode JA: Hyperthermicand endocrine effects of intravenous prostaglandin administration in the pig. Domest Anirn Endocrinol 1995;12:197-205.
55. Parrott RF, Veilucci SV, Goode JA, Lloyd DM, Forsling ML: Cyclo-oxygcna.se mediation of endotoxin-induced fever, anterior and posterior pituitary hormone release, and hypothalamic c-fos expression in the prepubertal pig. Exp Physiol 1995;80:663-674.